 BOSTON, Dec. 01, 2022 GLOBE NEWSWIRE Paratek Pharmaceuticals, Inc. Nasdaq: PRTK, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announced that on November 30, 2022, the Company granted restricted stock units to one new ... The post Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635c4... 